We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Proton Pencil Beam Scanner Installed at US University Hospital

By MedImaging International staff writers
Posted on 11 Apr 2017
Print article
Image: The MEVION S250i with HYPERSCAN proton-therapy pencil-beam scanning system (Photo courtesy of Mevion Medical Systems).
Image: The MEVION S250i with HYPERSCAN proton-therapy pencil-beam scanning system (Photo courtesy of Mevion Medical Systems).
The first installation of a novel, advanced, proton-therapy pencil beam scanning system that provides a new standard of Intensity Modulated Proton Therapy (IMPT) for cancer treatments, has taken place in a university hospital in the US.

The new standard combines fast energy-modulation with a sharp lateral penumbra, and is intended to improve treatment options for cancer patients.

The Mevion Medical Systems MEVION S250i with HYPERSCAN system was installed at the MedStar Georgetown University Hospital. A second system will be installed in a Netherlands’ clinic, and another in a cancer center in Florida, in the US.

The system uses Mevion Medical System’s proton multi-leaf collimator called Adaptive Aperture, a low-profile system designed specifically for the new MEVION S250i scanner. The system provides layer-by-layer beam collimation and can achieve collimated effective spot sizes of one to three millimeters, for all energies. The new system can be used to scan a typical lung tumor within two seconds or less, eliminating patient motion artifacts.

The MEVION S250mx is a scalable proton therapy solution for two to four-room designs that provide redundancy and 100% uptime. The MEVION S250i system with HYPERSCAN and Adaptive Aperture is currently pending clearance by the US FDA for clinical use.

President and CEO of Mevion Medical Systems, Joseph K. Jachinowski, said, "Mevion is proud to be working with MedStar Georgetown to achieve this milestone, and to be making proton therapy accessible to the Washington D.C. area. HYPERSCAN with Adaptive Aperture represents a real paradigm shift for the entire industry. This is the only proton system able to precisely shape each energy layer and deliver those layers at speeds up to 50 times faster than other systems. The results are highly conformal proton dose distributions that can be automatically adapted as treatment progresses."

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Under Table Shield
3 Section Double Pivot Under Table Shield
Digital Radiography Acquisition Software
VXvue with PureImpact
New
Thyroid Shield
Standard Thyroid Shield

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.